These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 15231872

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.
    Diamond SE, Chiono M, Gutierrez-Hartmann A.
    Mol Endocrinol; 1999 Feb; 13(2):228-38. PubMed ID: 9973253
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR, Eubank DW, Stocco DM.
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [Abstract] [Full Text] [Related]

  • 26. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
    Fujii M, Minamino T, Nomura M, Miyamoto KI, Tanaka J, Seiki M.
    Oncogene; 1996 May 16; 12(10):2193-202. PubMed ID: 8668346
    [Abstract] [Full Text] [Related]

  • 27. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M.
    Nature; 1991 Dec 12; 354(6353):494-6. PubMed ID: 1749429
    [Abstract] [Full Text] [Related]

  • 28. Promoter-specific trans-activation and inhibition mediated by JunB.
    Hsu JC, Cressman DE, Taub R.
    Cancer Res; 1993 Aug 15; 53(16):3789-94. PubMed ID: 8339292
    [Abstract] [Full Text] [Related]

  • 29. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
    Hadzopoulou-Cladaras M, Lavrentiadou SN, Zannis VI, Kardassis D.
    Biochemistry; 1998 Oct 06; 37(40):14078-87. PubMed ID: 9760243
    [Abstract] [Full Text] [Related]

  • 30. Activation of the murine thyrotropin beta-subunit promoter by GH4 rat pituitary cell-free extracts.
    Alexander LM, Williamson DJ, Wood WM, Gordon DF, Ridgway EC, Gutierrez-Hartmann A.
    Mol Endocrinol; 1990 Dec 06; 4(12):1887-96. PubMed ID: 2082187
    [Abstract] [Full Text] [Related]

  • 31. Characterization of sarcoma cell lines from v-jun transgenic mice.
    Marshall GM, Vanhamme L.
    Cancer Res; 1993 Feb 01; 53(3):622-6. PubMed ID: 8425197
    [Abstract] [Full Text] [Related]

  • 32. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex.
    Butticè G, Duterque-Coquillaud M, Basuyaux JP, Carrère S, Kurkinen M, Stéhelin D.
    Oncogene; 1996 Dec 05; 13(11):2297-306. PubMed ID: 8957070
    [Abstract] [Full Text] [Related]

  • 33. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A, Black EJ, Unlu M, Gillespie DA.
    Oncogene; 1996 Jun 06; 12(11):2409-18. PubMed ID: 8649782
    [Abstract] [Full Text] [Related]

  • 34. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
    Schuur ER, Parker EJ, Vogt PK.
    Cell Growth Differ; 1993 Sep 06; 4(9):761-8. PubMed ID: 8241024
    [Abstract] [Full Text] [Related]

  • 35. The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.
    Bos TJ, Rauscher FJ, Curran T, Vogt PK.
    Oncogene; 1989 Feb 06; 4(2):123-6. PubMed ID: 2494630
    [Abstract] [Full Text] [Related]

  • 36. Estrogen-mediated induction of rat prolactin gene transcription requires the formation of a chromatin loop between the distal enhancer and proximal promoter regions.
    Gothard LQ, Hibbard JC, Seyfred MA.
    Mol Endocrinol; 1996 Feb 06; 10(2):185-95. PubMed ID: 8825558
    [Abstract] [Full Text] [Related]

  • 37. [Stimulation of C-fos and jun B proto-oncogenes: potential role of TRH effects in clone cell line with prolactin (GH3B6)].
    Passegué E, Laverrière JN, Boulla G, Gourdji D.
    C R Seances Soc Biol Fil; 1995 Feb 06; 189(1):97-110. PubMed ID: 7648371
    [Abstract] [Full Text] [Related]

  • 38. Jun: stealth, stability, and transformation.
    Vogt PK, Bader AG.
    Mol Cell; 2005 Aug 19; 19(4):432-3. PubMed ID: 16109367
    [Abstract] [Full Text] [Related]

  • 39. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
    Maclaren A, Clark W, Black EJ, Gregory D, Fujii H, Gillespie DA.
    Oncogene; 2003 Apr 24; 22(16):2383-95. PubMed ID: 12717415
    [Abstract] [Full Text] [Related]

  • 40. A single domain of the estrogen receptor confers deoxyribonucleic acid binding and transcriptional activation of the rat prolactin gene.
    Waterman ML, Adler S, Nelson C, Greene GL, Evans RM, Rosenfeld MG.
    Mol Endocrinol; 1988 Jan 24; 2(1):14-21. PubMed ID: 3398840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.